george, i knew you would be the guy to get here to talk about this. i appreciate it. i appreciate ought of the work that you and your colleagues do in the fight against alzheimer s. i appreciate this conversation this morning. george vraidenberg is founder and co-chairman of us against alleges heimers. velshi is just getting started but let s take a quick look. second closest to the screen is jill biden in cornwall county, england. she is meeting with a group of volunteers, first responders, having some lunch as we can see at a picnic table while her husband, the president of the united states, is meeting with world leaders at the g7. we will continue to follow the g7 trip by the president and the first lady and the meeting of world leaders. we have revelations coming up that the department of justice seized data from congressional democrats. i will speak to congressman krishnamoorthi about that next. and senator debbie stabenow joins me to talk biden s agenda
he joins me now. george, good to see you, my friend. i thought of you immediately when this news came out. you have argued that this basically, don t let perfect be the enemy of the good, but others have argued this drug may not even be good. explain to me your perspective on it. well, patients that have no ambiguity about this. we have been waiting for another drug in alzheimer s for 18 years. this is the first disease-modifying drug, something that actually modifies underlying course of the disease. and there was evidence that it is going to positively affect clinical benefit, but the fda basically says, modifies the underlying course of the disease, let s do another trial to confirm our reasonable belief that, in fact, it has a clinical benefit. so they biogen will be required to do another study to confirm the clinical benefit